Clinical Trials Browser

Phase 2 × OTHER × Rabeprazole × Clear all

NCT07076914 2025-07-22

PPI-PROTECT

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT02747797 2018-08-02

Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations

Phase 2 Withdrawn

Acrocephalosyndactylia, Neoplasms